SCHEMBL8560002

SCHEMBL8560002

CCCn1c2nc(N3CCCCC3)[nH]c2c(=O)n2nc(Cc3ccccc3)nc12

nearest known ligand 0.58

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 2/20 0.58
ADORA3 P0DMS8 1/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
ADORA2A P29274 2/20 0.42
ADORA2B P29275 2/20 0.42
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7661252 0.84 ADORA1 (0.47) ADORA1ADORA3MEN1KMT2AADORA2A
SCHEMBL7656833 0.83 KMT2A (0.50) ADORA1ADORA3MEN1KMT2AADORA2A
SCHEMBL7657404 0.83 TSHR (0.46) ADORA1ADORA3MEN1KMT2AADORA2A
SCHEMBL8560750 0.77 PDE4A (0.52) ADORA1ADORA3ADORA2AADORA2BHSD17B10
SCHEMBL7001583 0.75 ADORA2A (0.49) ADORA3MEN1KMT2AADORA2AADORA2B
SCHEMBL9122257 0.74 ADORA1 (1.00) ADORA1ADORA3MEN1KMT2AADORA2A
SCHEMBL6868442 0.73 ADORA1 (1.00) ADORA1ADORA3MEN1KMT2AADORA2A
SCHEMBL8559651 0.73 ADORA2B (0.61) ADORA1ADORA3MEN1KMT2AADORA2A
SCHEMBL8562832 0.72 ADORA2B (0.43) ADORA1ADORA3ADORA2AADORA2BKDM4E
SCHEMBL8561695 0.70 ADORA2B (0.54) ADORA1ADORA3MEN1KMT2AADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0880524-A1 NEW TRIAZOLOPURINES, METHOD OF PREPARING THEM AND THEIR USE AS DRUGS Boehringer Ingelheim Pharma KG (DE) 1998-12-02 EP disclosed
WO-1998003511-A1 NEW TRIAZOLOPURINES, METHOD OF PREPARING THEM AND THEIR USE AS DRUGS BOEHRINGER INGELHEIM PHARMA KG (DE) 1998-01-29 WO disclosed